CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 266 filers reported holding CYTOKINETICS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460,599,440 | -8.1% | 15,634,740 | +1.8% | 0.01% | -7.1% |
| Q2 2023 | $501,114,085 | -2.6% | 15,362,173 | +5.0% | 0.01% | -6.7% |
| Q1 2023 | $514,667,193 | -25.0% | 14,625,382 | -2.3% | 0.02% | -28.6% |
| Q4 2022 | $685,802,464 | -2.8% | 14,967,317 | +2.7% | 0.02% | -12.5% |
| Q3 2022 | $705,918,000 | +33.9% | 14,569,992 | +8.6% | 0.02% | +41.2% |
| Q2 2022 | $527,008,000 | +9.6% | 13,413,296 | +2.7% | 0.02% | +30.8% |
| Q1 2022 | $480,908,000 | -18.5% | 13,064,618 | +0.9% | 0.01% | -13.3% |
| Q4 2021 | $590,305,000 | +24.5% | 12,950,964 | -2.4% | 0.02% | +15.4% |
| Q3 2021 | $474,017,000 | +105.5% | 13,262,947 | +13.8% | 0.01% | +116.7% |
| Q2 2021 | $230,641,000 | -16.9% | 11,654,402 | -2.3% | 0.01% | -25.0% |
| Q1 2021 | $277,433,000 | +15.0% | 11,927,444 | +2.7% | 0.01% | 0.0% |
| Q4 2020 | $241,277,000 | +3.6% | 11,611,079 | +7.9% | 0.01% | -11.1% |
| Q3 2020 | $232,952,000 | +5.6% | 10,759,951 | +14.9% | 0.01% | 0.0% |
| Q2 2020 | $220,654,000 | +105.1% | 9,361,689 | +2.6% | 0.01% | +80.0% |
| Q1 2020 | $107,586,000 | +6.1% | 9,125,191 | -4.6% | 0.01% | +25.0% |
| Q4 2019 | $101,438,000 | -3.8% | 9,560,602 | +3.2% | 0.00% | 0.0% |
| Q3 2019 | $105,450,000 | +3.5% | 9,266,237 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $101,905,000 | +42.1% | 9,058,271 | +2.2% | 0.00% | +33.3% |
| Q1 2019 | $71,699,000 | +30.0% | 8,862,826 | +1.6% | 0.00% | 0.0% |
| Q4 2018 | $55,153,000 | -35.6% | 8,726,571 | +0.3% | 0.00% | -25.0% |
| Q3 2018 | $85,680,000 | +29.9% | 8,698,387 | +9.5% | 0.00% | +33.3% |
| Q2 2018 | $65,934,000 | +26.2% | 7,943,794 | +9.5% | 0.00% | +50.0% |
| Q1 2018 | $52,253,000 | -11.4% | 7,257,257 | +0.2% | 0.00% | -33.3% |
| Q4 2017 | $59,001,000 | -40.6% | 7,239,394 | +5.7% | 0.00% | -40.0% |
| Q3 2017 | $99,266,000 | +31.3% | 6,845,900 | +9.6% | 0.01% | +25.0% |
| Q2 2017 | $75,609,000 | +93.4% | 6,248,605 | +105.4% | 0.00% | +100.0% |
| Q1 2017 | $39,089,000 | +97622.5% | 3,041,882 | +93438.8% | 0.00% | – |
| Q4 2016 | $40,000 | +42.9% | 3,252 | +6.9% | 0.00% | – |
| Q3 2016 | $28,000 | +16.7% | 3,041 | +15.8% | 0.00% | – |
| Q2 2016 | $24,000 | +60.0% | 2,627 | +28.5% | 0.00% | – |
| Q1 2016 | $15,000 | -40.0% | 2,045 | -14.3% | 0.00% | – |
| Q4 2015 | $25,000 | +4.2% | 2,387 | -35.3% | 0.00% | – |
| Q3 2015 | $24,000 | +380.0% | 3,687 | +368.5% | 0.00% | – |
| Q2 2015 | $5,000 | -44.4% | 787 | -41.7% | 0.00% | – |
| Q1 2015 | $9,000 | -18.2% | 1,350 | 0.0% | 0.00% | – |
| Q4 2014 | $11,000 | +120.0% | 1,350 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | +25.0% | 1,350 | +51.5% | 0.00% | – |
| Q2 2014 | $4,000 | -50.0% | 891 | 0.0% | 0.00% | – |
| Q1 2014 | $8,000 | +100.0% | 891 | +29.9% | 0.00% | – |
| Q4 2013 | $4,000 | -20.0% | 686 | 0.0% | 0.00% | – |
| Q3 2013 | $5,000 | – | 686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |